Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.

In agreement with the results above, addition of the respective CD4-Nb-modified vector particles and control vectors to these mixed cell cultures, followed by flow cytometry, clearly revealed preferred and highly significant transduction of the CD4-expressing subpopulation in the respective mixed cultures ( Fig 4A and 4B ).

also in 132,142 other papers